News

Check back often for the latest updates about our ETF in the news, press releases, special events and more.

news

A Q&A with Xencor

July 14, 2017

Xencor’s CEO describes his company’s efforts to improve antibody technology, including using bispecific antibodi...
Read More >

news

June 2017 ETF Rebalance

June 23, 2017

June 20th marked the semi-annual reconstitution and rebalance of the Cancer Immunotherapy ETF’s (Nasdaq: CNCR) underly...
Read More >